Login / Signup

Intravitreal anti-vascular endothelial growth factor and combined photodynamic therapy for pachychoroid neovasculopathy: long-term treatment outcomes.

Nobuya TanakaKeiko AzumaShuichiro AokiKohdai KitamotoKohei UedaRyosuke FujinoTatsuya InoueRyo Obata
Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2024)
In the treatment of PNV, regardless of the presence of polyps, the long-term visual outcomes were similar between the initial combined PDT and IVA TAE monotherapy. However, the annual number of anti-VEGF injections was lower in the initial combined PDT group than in the aflibercept TAE group, whereas that of PDT was comparable.
Keyphrases
  • vascular endothelial growth factor
  • photodynamic therapy
  • endothelial cells
  • fluorescence imaging
  • combination therapy
  • clinical trial
  • type diabetes
  • open label
  • insulin resistance
  • adipose tissue
  • replacement therapy